NASDAQ:OPNT - Opiant Pharmaceuticals News Headlines

Sign in or create an account to add this stock to your watchlist.
$14.56 +0.21 (+1.46 %)
(As of 07/19/2018 04:00 PM ET)
Previous Close$14.35
Today's Range$14.07 - $15.74
52-Week Range$8.75 - $51.90
Volume18,062 shs
Average Volume32,437 shs
Market Capitalization$40.73 million
P/E Ratio4.93
Dividend YieldN/A
Beta-0.72

Headlines

Opiant Pharmaceuticals (NASDAQ OPNT) News Headlines

Source:
DateHeadline
 Opiant Pharmaceuticals Inc (OPNT) Given $43.50 Average Target Price by Analysts Opiant Pharmaceuticals Inc (OPNT) Given $43.50 Average Target Price by Analysts
www.americanbankingnews.com - July 19 at 2:16 AM
Opiant Pharma up 20% premarketOpiant Pharma up 20% premarket
seekingalpha.com - July 12 at 4:42 PM
Head-To-Head Analysis: Vale (VALE) and Opiant Pharmaceuticals (OPNT)Head-To-Head Analysis: Vale (VALE) and Opiant Pharmaceuticals (OPNT)
www.americanbankingnews.com - July 9 at 4:18 PM
 Opiant Pharmaceuticals Inc (OPNT) Given Consensus Recommendation of "Strong Buy" by Brokerages Opiant Pharmaceuticals Inc (OPNT) Given Consensus Recommendation of "Strong Buy" by Brokerages
www.americanbankingnews.com - July 4 at 8:16 PM
Opiant Pharmaceuticals Announces Receipt of First Tranche from National Institutes of Health Grant for Development of OPNT003, Intranasal Nalmefene, for Treatment of Opioid OverdoseOpiant Pharmaceuticals Announces Receipt of First Tranche from National Institutes of Health Grant for Development of OPNT003, Intranasal Nalmefene, for Treatment of Opioid Overdose
finance.yahoo.com - June 25 at 5:27 PM
Opiant Pharmaceuticals (OPNT) "Overweight" Rating Reaffirmed at Cantor FitzgeraldOpiant Pharmaceuticals' (OPNT) "Overweight" Rating Reaffirmed at Cantor Fitzgerald
www.americanbankingnews.com - June 19 at 8:23 AM
Comparing Opiant Pharmaceuticals (OPNT) & Pretium Resources (PVG)Comparing Opiant Pharmaceuticals (OPNT) & Pretium Resources (PVG)
www.americanbankingnews.com - June 12 at 5:20 PM
Cantor Fitzgerald Begins Coverage on Opiant Pharmaceuticals (OPNT)Cantor Fitzgerald Begins Coverage on Opiant Pharmaceuticals (OPNT)
www.americanbankingnews.com - June 11 at 5:32 PM
Opiant Pharmaceuticals Inc (OPNT) Director Ann L. Macdougall Buys 5,000 SharesOpiant Pharmaceuticals Inc (OPNT) Director Ann L. Macdougall Buys 5,000 Shares
www.americanbankingnews.com - June 5 at 8:16 PM
Opiant Pharmaceuticals to Participate in Opioid Panel at the BIO International ConventionOpiant Pharmaceuticals to Participate in Opioid Panel at the BIO International Convention
finance.yahoo.com - June 4 at 5:05 PM
Opiant Pharmaceuticals (OPNT) and SOUTH32 Ltd/S (SOUHY) Head-To-Head AnalysisOpiant Pharmaceuticals (OPNT) and SOUTH32 Ltd/S (SOUHY) Head-To-Head Analysis
www.americanbankingnews.com - June 2 at 11:34 AM
Opiant Pharmaceuticals to Participate in The American Society of Clinical Psychopharmacology 2018 Annual MeetingOpiant Pharmaceuticals to Participate in The American Society of Clinical Psychopharmacology 2018 Annual Meeting
finance.yahoo.com - May 29 at 8:32 AM
Comparing Turquoise Hill Resources (TRQ) & Opiant Pharmaceuticals (OPNT)Comparing Turquoise Hill Resources (TRQ) & Opiant Pharmaceuticals (OPNT)
www.americanbankingnews.com - May 28 at 1:16 AM
Report: Exploring Fundamental Drivers Behind Opiant Pharmaceuticals, American Railcar Industries, Omega Flex, Johnson Outdoors, Thermon Group, and Connecticut Water Service — New Horizons, Emerging Trends, and Upcoming DevelopmentsReport: Exploring Fundamental Drivers Behind Opiant Pharmaceuticals, American Railcar Industries, Omega Flex, Johnson Outdoors, Thermon Group, and Connecticut Water Service — New Horizons, Emerging Trends, and Upcoming Developments
finance.yahoo.com - May 25 at 8:27 AM
Thomas T. Thomas Sells 2,763 Shares of Opiant Pharmaceuticals (OPNT) StockThomas T. Thomas Sells 2,763 Shares of Opiant Pharmaceuticals (OPNT) Stock
www.americanbankingnews.com - May 18 at 8:35 PM
Opiant Pharmaceuticals (OPNT) versus Nornickel (NILSY) Head to Head ContrastOpiant Pharmaceuticals (OPNT) versus Nornickel (NILSY) Head to Head Contrast
www.americanbankingnews.com - May 18 at 5:31 PM
Q2 2018 Earnings Estimate for Opiant Pharmaceuticals Issued By Zacks Investment Research (OPNT)Q2 2018 Earnings Estimate for Opiant Pharmaceuticals Issued By Zacks Investment Research (OPNT)
www.americanbankingnews.com - May 17 at 6:45 AM
Insider Buying: Opiant Pharmaceuticals (OPNT) CFO Buys 2,000 Shares of StockInsider Buying: Opiant Pharmaceuticals (OPNT) CFO Buys 2,000 Shares of Stock
www.americanbankingnews.com - May 16 at 8:52 PM
Opiant Pharmaceuticals (OPNT) Director Thomas T. Thomas Sells 4,300 SharesOpiant Pharmaceuticals (OPNT) Director Thomas T. Thomas Sells 4,300 Shares
www.americanbankingnews.com - May 15 at 8:16 PM
OPNT: KOL Event Highlights Medications for Addictions and Related DisordersOPNT: KOL Event Highlights Medications for Addictions and Related Disorders
finance.yahoo.com - May 15 at 5:41 PM
Insider Buying: Opiant Pharmaceuticals (OPNT) CFO Buys 3,000 Shares of StockInsider Buying: Opiant Pharmaceuticals (OPNT) CFO Buys 3,000 Shares of Stock
www.americanbankingnews.com - May 14 at 4:33 PM
Opiant Pharmaceuticals, Inc. Reports First Quarter 2018 Financial Results and Provides Corporate UpdateOpiant Pharmaceuticals, Inc. Reports First Quarter 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - May 8 at 5:28 PM
Head to Head Comparison: Opiant Pharmaceuticals (OPNT) vs. Uranium Resources (WWR)Head to Head Comparison: Opiant Pharmaceuticals (OPNT) vs. Uranium Resources (WWR)
www.americanbankingnews.com - May 6 at 11:31 AM
Opiant Pharmaceuticals To Host Key Opinion Leader Meeting on Medications for Addictions and Related DisordersOpiant Pharmaceuticals To Host Key Opinion Leader Meeting on Medications for Addictions and Related Disorders
finance.yahoo.com - May 3 at 8:26 AM
Blog Exposure - Opiant Pharma Receives Grant for Development of OPNT003 for Treatment of Opioid OverdoseBlog Exposure - Opiant Pharma Receives Grant for Development of OPNT003 for Treatment of Opioid Overdose
finance.yahoo.com - April 20 at 8:36 AM
Opiant Pharmaceuticals Awarded Grant of Approximately $7.4 Million from the National Institutes of Health for ...Opiant Pharmaceuticals Awarded Grant of Approximately $7.4 Million from the National Institutes of Health for ...
globenewswire.com - April 19 at 8:26 AM
BRIEF-Opiant Pharmaceuticals Awarded Grant Of Approximately $7.4 Mln From The National Institutes Of HealthBRIEF-Opiant Pharmaceuticals Awarded Grant Of Approximately $7.4 Mln From The National Institutes Of Health
www.reuters.com - April 19 at 8:26 AM
Opiant awarded $7.4M NIH grant to support OPNT003 development; shares ahead 2% premarketOpiant awarded $7.4M NIH grant to support OPNT003 development; shares ahead 2% premarket
seekingalpha.com - April 18 at 5:37 PM
Opiant Pharmaceuticals Awarded Grant of Approximately $7.4 Million from the National Institutes of Health for Development of OPNT003, Intranasal Nalmefene, for Treatment of Opioid OverdoseOpiant Pharmaceuticals Awarded Grant of Approximately $7.4 Million from the National Institutes of Health for Development of OPNT003, Intranasal Nalmefene, for Treatment of Opioid Overdose
finance.yahoo.com - April 18 at 8:26 AM
Will Opiant Pharma Solve The Biggest Crisis That The FDA Is Currently Facing?Will Opiant Pharma Solve The Biggest Crisis That The FDA Is Currently Facing?
seekingalpha.com - April 11 at 8:42 AM
ValuEngine Upgrades Opiant Pharmaceuticals (OPNT) to Strong-BuyValuEngine Upgrades Opiant Pharmaceuticals (OPNT) to Strong-Buy
www.americanbankingnews.com - April 9 at 11:35 AM
Opiant Pharmaceuticals (OPNT) Stock Rating Lowered by ValuEngineOpiant Pharmaceuticals (OPNT) Stock Rating Lowered by ValuEngine
www.americanbankingnews.com - April 8 at 11:17 AM
Opiant Pharmaceuticals (OPNT) Lifted to B at TheStreetOpiant Pharmaceuticals (OPNT) Lifted to B at TheStreet
www.americanbankingnews.com - April 6 at 4:46 PM
Opiant Pharmaceuticals (OPNT) Lifted to "Hold" at ValuEngineOpiant Pharmaceuticals (OPNT) Lifted to "Hold" at ValuEngine
www.americanbankingnews.com - April 5 at 1:11 PM
ValuEngine Lowers Opiant Pharmaceuticals (OPNT) to BuyValuEngine Lowers Opiant Pharmaceuticals (OPNT) to Buy
www.americanbankingnews.com - April 4 at 5:19 PM
Zacks: Brokerages Anticipate Opiant Pharmaceuticals Inc (OPNT) to Post -$0.29 Earnings Per ShareZacks: Brokerages Anticipate Opiant Pharmaceuticals Inc (OPNT) to Post -$0.29 Earnings Per Share
www.americanbankingnews.com - April 4 at 1:22 PM
Free Research Report as HubSpot’s Quarterly Earnings Surpassed Analysts’ EstimatesFree Research Report as HubSpot’s Quarterly Earnings Surpassed Analysts’ Estimates
finance.yahoo.com - March 22 at 8:38 AM
Trump says he is working to lower prescription drug pricesTrump says he is working to lower prescription drug prices
finance.yahoo.com - March 20 at 8:40 AM
As U.S. opioid crisis grows, Trump calls for death penalty for dealersAs U.S. opioid crisis grows, Trump calls for death penalty for dealers
finance.yahoo.com - March 20 at 8:40 AM
OPNT: Opiant Developing New Opioid Overdose TreatmentOPNT: Opiant Developing New Opioid Overdose Treatment
finance.yahoo.com - March 19 at 5:10 PM
Opiant Pharmaceuticals, Inc. to Present a Corporate Overview at the Oppenheimer 28th Annual Healthcare ConferenceOpiant Pharmaceuticals, Inc. to Present a Corporate Overview at the Oppenheimer 28th Annual Healthcare Conference
finance.yahoo.com - March 19 at 5:10 PM
Kadmon (KDMN) & Opiant Pharmaceuticals (OPNT) Critical AnalysisKadmon (KDMN) & Opiant Pharmaceuticals (OPNT) Critical Analysis
www.americanbankingnews.com - March 12 at 10:27 AM
Opiant Pharmaceuticals (OPNT) and Syros Pharmaceuticals (SYRS) Critical ReviewOpiant Pharmaceuticals (OPNT) and Syros Pharmaceuticals (SYRS) Critical Review
www.americanbankingnews.com - March 10 at 12:17 PM
Opiant Pharmaceuticals, Inc. Reports Financial Results for August 1, 2017, Through December 31, 2017, and Provides ... - GlobeNewswire (press release)Opiant Pharmaceuticals, Inc. Reports Financial Results for August 1, 2017, Through December 31, 2017, and Provides ... - GlobeNewswire (press release)
globenewswire.com - March 9 at 8:35 AM
Opiant Pharmaceuticals reports 5M resultsOpiant Pharmaceuticals reports 5M results
seekingalpha.com - March 7 at 6:23 PM
Opiant Pharmaceuticals, Inc. Reports Financial Results for August 1, 2017, Through December 31, 2017, and Provides Corporate UpdateOpiant Pharmaceuticals, Inc. Reports Financial Results for August 1, 2017, Through December 31, 2017, and Provides Corporate Update
finance.yahoo.com - March 7 at 6:23 PM
Opiant Pharmaceuticals (OPNT) to Release Earnings on WednesdayOpiant Pharmaceuticals (OPNT) to Release Earnings on Wednesday
www.americanbankingnews.com - March 7 at 1:50 AM
Aegis Awarded Patent for Fast Acting Nasal Spray Opioid Blockers and Pain Medications - GlobeNewswire (press release)Aegis Awarded Patent for Fast Acting Nasal Spray Opioid Blockers and Pain Medications - GlobeNewswire (press release)
globenewswire.com - February 22 at 8:30 AM
Aegis Awarded Patent for Fast Acting Nasal Spray Opioid Blockers and Pain MedicationsAegis Awarded Patent for Fast Acting Nasal Spray Opioid Blockers and Pain Medications
finance.yahoo.com - February 22 at 8:30 AM
Q2 2018 EPS Estimates for Opiant Pharmaceuticals Inc Lifted by Analyst (OPNT)Q2 2018 EPS Estimates for Opiant Pharmaceuticals Inc Lifted by Analyst (OPNT)
www.americanbankingnews.com - February 15 at 10:18 AM
This page was last updated on 7/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.